Researchers have integrated perovskite solar cells with copper nano-flowers that utilize sunlight to convert CO2 into complex ...

A postdoctoral researcher in the department of physics and biology at Princeton University gave a guest lecture about a ...

SEONGNAM, Gyeonggi Province — Hyundai Motor launched the second generation of the Palisade, its three-row family SUV, aiming to boost demand for premium family cars. The redesigned model made ...

Hyundai Motor Company has unveiled the All New Palisade, the first revamped version of its flagship large-sized SUV in six years, featuring premium upgrades to its driving performance and ...

Following countless reports, rumors, spy photos of various prototypes, and the ubiquitous pre-release renderings, the all-new 2026 Hyundai Palisade three-row nine-seater finally became official in ...

The Palisade is offered with two powertrains: a 2.5-liter gasoline-powered, turbocharged engine and a 2.5-liter hybrid engine, the automaker’s first-ever attempt at a hybrid 2.5-liter turbocharged, ...

Swiss IoT module maker u-blox is to phase out its loss-making cellular IoT business, the firm has said. The division has over 200 employees; jobs are expected to go with its closure. It made revenue ...

The network is called Lunar Surface Communication System (LSCS), and it is basically a replica of the 4G/LTE cellular technology currently used on a very large scale by the humans of Earth.

MALIBU, Calif. – A man and woman returned to what remained of their home in Malibu on Sunday, after the Palisades wildfire burned it and several other homes to the ground. Video showed the couple ...

Containment grew on both the Eaton and the Palisades fires before anticipated dangerous winds started hitting the region. The Eaton fire, burning in Altadena and Pasadena, was 35% contained as of ...

(AP Photo/Ted Shaffrey, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...